Great post Clarke,
Yes, the article seemed to state very matter of factly that the trials will begin 'end of September' so looks like things are lining up.
Additional to the FDA submission, no one is speaking about the CE accreditation. The cap raising was done to accelerate the path to the US and European markets....
Cheers
CT
RAP Price at posting:
50.0¢ Sentiment: Buy Disclosure: Held